These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

700 related items for PubMed ID: 25557757

  • 1. Emerging hormonal treatments for menopausal symptoms.
    Genazzani AR, Komm BS, Pickar JH.
    Expert Opin Emerg Drugs; 2015 Mar; 20(1):31-46. PubMed ID: 25557757
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms.
    Archer DF.
    Drugs Aging; 2010 Jul 01; 27(7):533-44. PubMed ID: 20583848
    [Abstract] [Full Text] [Related]

  • 5. Hormone Therapy and Other Treatments for Symptoms of Menopause.
    Hill DA, Crider M, Hill SR.
    Am Fam Physician; 2016 Dec 01; 94(11):884-889. PubMed ID: 27929271
    [Abstract] [Full Text] [Related]

  • 6. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
    Pickar JH, Komm BS.
    Post Reprod Health; 2015 Sep 01; 21(3):112-21. PubMed ID: 26289836
    [Abstract] [Full Text] [Related]

  • 7. Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.
    Pickar JH, Mirkin S.
    Menopause Int; 2010 Sep 01; 16(3):121-8. PubMed ID: 20956688
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause.
    Wurz GT, Kao CJ, DeGregorio MW.
    Clin Interv Aging; 2014 Sep 01; 9():1939-50. PubMed ID: 25419123
    [Abstract] [Full Text] [Related]

  • 9. Current and evolving approaches to individualizing estrogen receptor-based therapy for menopausal women.
    Santen RJ, Kagan R, Altomare CJ, Komm B, Mirkin S, Taylor HS.
    J Clin Endocrinol Metab; 2014 Mar 01; 99(3):733-47. PubMed ID: 24423357
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.
    Sharifi M, Lewiecki EM.
    Expert Rev Clin Pharmacol; 2014 May 01; 7(3):281-91. PubMed ID: 24580081
    [Abstract] [Full Text] [Related]

  • 12. Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss.
    Komm BS, Mirkin S, Jenkins SN.
    Steroids; 2014 Nov 01; 90():71-81. PubMed ID: 24929044
    [Abstract] [Full Text] [Related]

  • 13. Bazedoxifene/conjugated estrogens for managing the burden of estrogen deficiency symptoms.
    Mirkin S, Ryan KA, Chandran AB, Komm BS.
    Maturitas; 2014 Jan 01; 77(1):24-31. PubMed ID: 24246155
    [Abstract] [Full Text] [Related]

  • 14. Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
    Palacios S, Currie H, Mikkola TS, Dragon E.
    Maturitas; 2015 Apr 01; 80(4):435-40. PubMed ID: 25684082
    [Abstract] [Full Text] [Related]

  • 15. Advances in menopausal therapy: the tissue-selective estrogen complex.
    Moore A.
    J Am Assoc Nurse Pract; 2013 Mar 01; 25(3):126-33. PubMed ID: 24218199
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.